248 related articles for article (PubMed ID: 16168039)
1. Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?
Creed F; Guthrie E; Ratcliffe J; Fernandes L; Rigby C; Tomenson B; Read N; Thompson DG;
Aust N Z J Psychiatry; 2005 Sep; 39(9):807-15. PubMed ID: 16168039
[TBL] [Abstract][Full Text] [Related]
2. Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome.
Guthrie E; Barlow J; Fernandes L; Ratcliffe J; Read N; Thompson DG; Tomenson B; Creed F;
Psychosom Med; 2004; 66(4):578-82. PubMed ID: 15272106
[TBL] [Abstract][Full Text] [Related]
3. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome.
Creed F; Tomenson B; Guthrie E; Ratcliffe J; Fernandes L; Read N; Palmer S; Thompson DG
J Psychosom Res; 2008 Jun; 64(6):613-20. PubMed ID: 18501262
[TBL] [Abstract][Full Text] [Related]
4. The interface of psychiatry and irritable bowel syndrome.
Folks DG
Curr Psychiatry Rep; 2004 Jun; 6(3):210-5. PubMed ID: 15142474
[TBL] [Abstract][Full Text] [Related]
5. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
Goodoory VC; Mikocka-Walus A; Yiannakou Y; Houghton LA; Black CJ; Ford AC
Am J Gastroenterol; 2021 Jul; 116(7):1485-1494. PubMed ID: 33840729
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome, anxiety, depression and personality characteristics.
Tosic-Golubovic S; Miljkovic S; Nagorni A; Lazarevic D; Nikolic G
Psychiatr Danub; 2010 Sep; 22(3):418-24. PubMed ID: 20856185
[TBL] [Abstract][Full Text] [Related]
7. Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
Han C; Masand PS; Krulewicz S; Peindl K; Mannelli P; Varia IM; Pae CU; Patkar AA
J Clin Pharm Ther; 2009 Feb; 34(1):79-88. PubMed ID: 19125906
[TBL] [Abstract][Full Text] [Related]
8. Childhood adversity and frequent medical consultations.
Fiddler M; Jackson J; Kapur N; Wells A; Creed F
Gen Hosp Psychiatry; 2004; 26(5):367-77. PubMed ID: 15474636
[TBL] [Abstract][Full Text] [Related]
9. The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity.
Lackner JM; Gudleski GD; Thakur ER; Stewart TJ; Iacobucci GJ; Spiegel BM
Am J Gastroenterol; 2014 Feb; 109(2):224-33. PubMed ID: 24419481
[TBL] [Abstract][Full Text] [Related]
10. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.
Schwille-Kiuntke J; Enck P; Zendler C; Krieg M; Polster AV; Klosterhalfen S; Autenrieth IB; Zipfel S; Frick JS
Neurogastroenterol Motil; 2011 Nov; 23(11):e479-88. PubMed ID: 21883703
[TBL] [Abstract][Full Text] [Related]
11. Anxiety disorders and comorbid medical illness.
Roy-Byrne PP; Davidson KW; Kessler RC; Asmundson GJ; Goodwin RD; Kubzansky L; Lydiard RB; Massie MJ; Katon W; Laden SK; Stein MB
Gen Hosp Psychiatry; 2008; 30(3):208-25. PubMed ID: 18433653
[TBL] [Abstract][Full Text] [Related]
12. Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs.
Katon W; Von Korff M; Lin E; Lipscomb P; Russo J; Wagner E; Polk E
Gen Hosp Psychiatry; 1990 Nov; 12(6):355-62. PubMed ID: 2245919
[TBL] [Abstract][Full Text] [Related]
13. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome.
Creed F; Guthrie E; Ratcliffe J; Fernandes L; Rigby C; Tomenson B; Read N; Thompson DG
Psychosom Med; 2005; 67(3):490-9. PubMed ID: 15911915
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule.
Choung RS; Locke GR; Zinsmeister AR; Schleck CD; Talley NJ
Am J Gastroenterol; 2009 Jul; 104(7):1772-9. PubMed ID: 19491833
[TBL] [Abstract][Full Text] [Related]
15. An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder.
Kaplan A; Franzen MD; Nickell PV; Ransom D; Lebovitz PJ
Int J Psychiatry Clin Pract; 2014 Jan; 18(1):11-5. PubMed ID: 23980534
[TBL] [Abstract][Full Text] [Related]
16. Multiple medically unexplained physical symptoms and health care utilization: outcome of psychological intervention and patient-related predictors of change.
Kolk AM; Schagen S; Hanewald GJ
J Psychosom Res; 2004 Oct; 57(4):379-89. PubMed ID: 15518674
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant treatment outcomes of psychogenic movement disorder.
Voon V; Lang AE
J Clin Psychiatry; 2005 Dec; 66(12):1529-34. PubMed ID: 16401153
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and therapeutic characteristics of social phobia in French psychiatry (Phoenix study)].
Pélissolo A; Huron C; Fanget F; Servant D; Stiti S; Richard-Berthe C; Boyer P
Encephale; 2006; 32(1 Pt 1):106-12. PubMed ID: 16633297
[TBL] [Abstract][Full Text] [Related]
19. Do Symptoms of Irritable Bowel Syndrome Improve when Patients Receive Cognitive Behavioural Therapy for Co-morbid Anxiety Disorders in a Primary Care Psychological Therapy (IAPT) Service?
Kenwright M; McDonald J; Talbot J; Janjua K
Behav Cogn Psychother; 2017 Sep; 45(5):433-447. PubMed ID: 28478779
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between depression, anxiety and heart disease - a psychosomatic challenge].
Kapfhammer HP
Psychiatr Danub; 2011 Dec; 23(4):412-24. PubMed ID: 22075746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
